341 related articles for article (PubMed ID: 25444748)
1. Biomarkers for neuromyelitis optica.
Chang KH; Ro LS; Lyu RK; Chen CM
Clin Chim Acta; 2015 Feb; 440():64-71. PubMed ID: 25444748
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of neuromyelitis optica].
Fujihara K
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(2):129-35. PubMed ID: 22576570
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of neuromyelitis optica].
Misu T; Fujihara K
Nihon Rinsho; 2013 May; 71(5):823-8. PubMed ID: 23777089
[TBL] [Abstract][Full Text] [Related]
4. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
6. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
7. [NMO spectrum disorders and anti AQP4 antibody].
Takai Y; Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2013 Apr; 65(4):333-43. PubMed ID: 23568981
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica and astrocytic damage in its pathogenesis.
Fujihara K
J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
[TBL] [Abstract][Full Text] [Related]
9. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Lucchinetti CF; Guo Y; Popescu BF; Fujihara K; Itoyama Y; Misu T
Brain Pathol; 2014 Jan; 24(1):83-97. PubMed ID: 24345222
[TBL] [Abstract][Full Text] [Related]
10. A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.
Takano R; Misu T; Takahashi T; Izumiyama M; Fujihara K; Itoyama Y
Tohoku J Exp Med; 2008 May; 215(1):55-9. PubMed ID: 18509235
[TBL] [Abstract][Full Text] [Related]
11. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
[TBL] [Abstract][Full Text] [Related]
12. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
13. Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.
Ringelstein M; Ayzenberg I; Harmel J; Lauenstein AS; Lensch E; Stögbauer F; Hellwig K; Ellrichmann G; Stettner M; Chan A; Hartung HP; Kieseier B; Gold R; Aktas O; Kleiter I
JAMA Neurol; 2015 Jul; 72(7):756-63. PubMed ID: 25985228
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Uzawa A; Mori M; Kuwabara S
Brain Pathol; 2014 Jan; 24(1):67-73. PubMed ID: 24345220
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
Kira J
J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
[TBL] [Abstract][Full Text] [Related]
16. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
17. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
18. [Biomarkers in neuromyelitis optica].
Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2012 May; 64(5):525-35. PubMed ID: 22570066
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
Carnero Contentti E; Correale J
J Neuroinflammation; 2021 Sep; 18(1):208. PubMed ID: 34530847
[TBL] [Abstract][Full Text] [Related]
20. [New insights into the pathogenesis of neuromyelitis optica].
Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y
Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]